• Study reveals Singaporeans unaware of higher colorectal cancer risk in relatives of patients
    First-degree relatives, who are at a higher risk of developing colorectal cancer, are not aware of their increased risk – and are not taking the necessary screening steps, a recent study shows.
  • China imposes extreme punishments to counter fake clinical trial data submissions
    China has announced a policy shift on 11 May, which sentences those who submit faked clinical trial data into jail; and in extreme circumstances be executed. The shift was sparked after China's Food and Drug Administration (CFDA) ordered companies to re-evaluate "the authenticity, integrity and compliance of clinical trial data" – in pending applications for new drugs in 2015. Does this mean an improved approval process for the CFDA?
  • Viral fingerprinting to combat deadly viruses
    The human virome was discovered to leave an “indelible footprint on the immune system”. Research has shown that these antibodies will remain in the host years after the initial acute infection and constitute a pattern very much like our fingerprints.
  • The lack of rare disease policies in Hong Kong and what we can learn from Taiwan
    Hong Kong has no clear definition of rare diseases, nor does the government have an accurate count of local incidences or established any formulated funding policy to support rare disease patients. In stark contrast, Taiwan has long shown the utmost support and commitment towards their rare disease patients’ needs and concerns. Is there anything Hong Kong can learn from Taiwan?
  • The converging lines between tech giants and healthcare
    Tech giants such as Apple and Google are developing cutting edge technology to break into healthcare, for example, a non-invasive glucose monitoring device to help diabetic patients.
  • 6 bizarre ancient contraceptive methods
    Dating back to the 1800s, contraception has beckoned innovation with many hits and misses. These old methods put the safety and efficacy of family planning today into perspective.
  • First trace-back of a tumour unveils how cancer spreads
    A recent study done by the Institute of Cancer Research UK looked at the development of a tumour in a patient after a biopsy had a rare side effect - it left behind a trail of cells from the tumour as doctors withdrew the needle. The researchers suggest that studies like these and the tools they use will be critical in the future management of cancer.
  • Up to one third of FDA drugs have severe safety issues
    Amid calls for faster reviews from lawmakers and the Trump administration, researchers found about a third of FDA-approved drugs have major safety issues.
  • How to manage patients with adverse medical reactions
    Some physicians worry that explaining potential side effects of adverse drug reactions to patients may increase their occurrence. However, if potential risks are clearly explained in advance, patients will have fewer concerns and hence handle them better.
  • Healthcare spending around the world
    Data spanning across 184 countries shows how some of the nations stood out in terms of their healthcare spending.
  • Science Bites: Common antibiotics linked to increased risk of miscarriage, Smoking during pregnancy tied to autism in granddaughters
    Study findings have discovered an association between five common classes of antibiotics and an increased risk of spontaneous abortion in early stages of pregnancy. Meanwhile, researchers suggest that a carefully timed pregnancy may prevent miscarriage.
  • HKU invents new laser technology that enables cancer to be diagnosed earlier
    In April 2017, Dr Kevin Tsia, Associate Professor in Department of Electrical and Electronic Engineering at the University of Hong Kong (HKU) and his research team invented an innovative laser imaging technology, producing promising results to reduce cancer diagnosis duration from approximately one week to only two minutes.
  • New guideline recommends against world’s most common knee surgery
    The world’s most common orthopaedic surgery, knee arthroscopy, is not recommended for patients with degenerative knee disease as a study found minimal benefits it brings to patients.